Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Belinostat

EU orphan designation number: EU/3/13/1151   
Active ingredient: Belinostat
Indication: Treatment of malignant thymoma
Sponsor: TopoTarget A/S
Fruebjergvej 3, DK-2100 KÝbenhavn, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2013 Centralised Orphan - Designation EMA/OD/036/13 (2013)4725 of 17/07/2013
01/10/2013 Corrigendum (2013)6436 of 27/09/2013